Should therapeutic cannabis be regulated?

Can we lawfully buy and consume cannabis in France today? Yes and no. Yes, since the state has actually unwinded its regulations on CBD, including through the Minister of Health. And no, at the same time, since just products containing cannabidiol (CBD), an active compound that does not have the psychedelic results attributed to THC, are thought about legal. Let us take stock of what is legal and what is not with regard to cannabis and CBD.

CBD is legal in France, however THC is not

Marijuana ought to not be confused with cannabidiol. Especially since the second is legal in specific forms in France … While the other is not! Since cannabidiol (understood by the acronym CBD) is just among the many active substances from the hemp plant, which does not have the psychedelic results of its cousin THC – the one that makes you “stone”.

In short, what is usually called “cannabis”, which consists of high concentrations of THC (tetrahydrocannabinol) is still thought about a narcotic product. And therefore illegal in France as in many countries in the world. On the other hand, cannabis which offers pride of place to the cannabinoid called cannabidiol, it is legal as long as its THC levels do not surpass 0.2%.

Nevertheless, the legislation remains vague in France on this subject. Presently, there is no law that makes it clear whether CBD is legal or not. Concretely, it is licensed for sale in the form of E-liquid, to be used in an electronic cigarette. However it is also found in other forms (including oil or paste), without its purchase and intake being reprehensible … To attempt to make it easy, let’s say that CBD is not restricted by French law, unlike THC

CBD vs THC.

Although CBD and THC are indistinguishable, they are extremely various. These are the best understood of the 500 cannabinoids found in hemp. And each has its specific results. THC is particularly understood for its psychedelic homes: it triggers a modification in the state of awareness by acting directly on the brain. By taking in cannabis abundant in THC, we “hover”: well-being, euphoria, relaxation … But also red eyes, dilated pupils and, sometimes, anxiety or even paranoia.

CBD has nothing to do with it. It is not euphoric. It does not cause anxiety or anxiety attacks. On the contrary: cannabidiol remains in the procedure of making its way by virtue of its advantageous therapeutic results. CBD helps relieve pain and swelling, reduce anxiety, reduce the suffering of victims of anxiety attacks and depression, and even treat specific diseases (such as epilepsy or Alzheimer’s). In addition, it has a really low toxicity and presents (almost) no addicting danger, even if the lack of clinical studies lowers these attributes to simple hypotheses.

Legalization of CBD in France: should we go even more?

Certainly, the legal development relating to CBD is positive, however everything remains to be done. The health ministry wants to be cautious, and the federal government’s position on the matter resembles a balancing act. At the same time, the National Medicines Agency has actually plainly spoken up. We therefore look after the goat and the cabbage so as not to get too involved, while the vaporized cannabidiol has actually been readily available in France for a few years already, making the most of the legal vagueness that continues.

Beyond the 0.2% THC threshold licensed in marketed products, it ought to be borne in mind that just the liquid form of CBD (intended for electric cigarettes) is truly legal. The purchase and intake of resin or smoking cigarettes herb is therefore not controlled, especially since the THC level is often greater (around 15%). In addition, just making use of seeds and fibers is licensed in France. However what about midnight CBD oil, which enables you to delight in the advantages of the compound without exposing your lungs to possibly harmful smoke? What about CBD paste? On these subjects, there is radio silence.

In addition, composite CBD is thought about a “dietary supplement”, which prohibits presenting it as a medication. And make it an informed ad for users and clients. Regrettable, since, in the meantime, many prospective beneficiaries are not making the most of it. It is therefore necessary to go even more and clarify things: more than a question of consumer well-being, it refers public health.

Scroll to top